Forbes selected biotechnological companies in China & Hong Kong 2018, based on sales

Leading companies in biotechnology and drugs in mainland China and Hong Kong according to Forbes in 2018, based on sales value (in million U.S. dollars)*

Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

July 2019

Region

China, Hong Kong

Survey time period

FY2018

Supplementary notes

*The data are based on Forbes Asia's 200 Best Under a Billion 2019 listing which includes only stock traded Asia-Pacific companies with annual revenue between five million and one billion U.S. dollars. From 24,000 candidates, roughly 1,400 passed Forbes' criteria for profitability, growth, and modest indebtedness. Forbes' selection of 200 finalists is un-ranked. The values represent the results of the most recent fiscal year.

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry

10

About the region

10

Selected statistics

5

Other regions

10

Related statistics

10

Further related statistics

10
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.